These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 29301568)

  • 21. Overexpression of CNTF in Mesenchymal Stem Cells reduces demyelination and induces clinical recovery in experimental autoimmune encephalomyelitis mice.
    Lu Z; Hu X; Zhu C; Wang D; Zheng X; Liu Q
    J Neuroimmunol; 2009 Jan; 206(1-2):58-69. PubMed ID: 19081144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple functional therapeutic effects of TnP: A small stable synthetic peptide derived from fish venom in a mouse model of multiple sclerosis.
    Komegae EN; Souza TA; Grund LZ; Lima C; Lopes-Ferreira M
    PLoS One; 2017; 12(2):e0171796. PubMed ID: 28235052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A sulfated disaccharide derived from chondroitin sulfate proteoglycan protects against inflammation-associated neurodegeneration.
    Rolls A; Cahalon L; Bakalash S; Avidan H; Lider O; Schwartz M
    FASEB J; 2006 Mar; 20(3):547-9. PubMed ID: 16396993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inactivation of sphingosine-1-phosphate receptor 2 (S1PR2) decreases demyelination and enhances remyelination in animal models of multiple sclerosis.
    Seyedsadr MS; Weinmann O; Amorim A; Ineichen BV; Egger M; Mirnajafi-Zadeh J; Becher B; Javan M; Schwab ME
    Neurobiol Dis; 2019 Apr; 124():189-201. PubMed ID: 30468865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate.
    Aharoni R; Vainshtein A; Stock A; Eilam R; From R; Shinder V; Arnon R
    J Autoimmun; 2011 Nov; 37(3):228-41. PubMed ID: 21752599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Valproic acid ameliorates inflammation in experimental autoimmune encephalomyelitis rats.
    Zhang Z; Zhang ZY; Wu Y; Schluesener HJ
    Neuroscience; 2012 Sep; 221():140-50. PubMed ID: 22800566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DAB
    Bhopale MK; Hilliard B; Constantinescu CS; Phillips SM; Rostami A
    Immunopharmacol Immunotoxicol; 2017 Dec; 39(6):318-329. PubMed ID: 28929835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of CC chemokines and their receptors in the eye in autoimmune anterior uveitis associated with EAE.
    Adamus G; Manczak M; Machnicki M
    Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2894-903. PubMed ID: 11687534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.
    Ingwersen J; Wingerath B; Graf J; Lepka K; Hofrichter M; Schröter F; Wedekind F; Bauer A; Schrader J; Hartung HP; Prozorovski T; Aktas O
    J Neuroinflammation; 2016 Feb; 13():48. PubMed ID: 26920550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Huperzine A inhibits CCL2 production in experimental autoimmune encephalomyelitis mice and in cultured astrocyte.
    Tian GX; Zhu XQ; Chen Y; Wu GC; Wang J
    Int J Immunopathol Pharmacol; 2013; 26(3):757-64. PubMed ID: 24067473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GABA transport and neuroinflammation are coupled in multiple sclerosis: regulation of the GABA transporter-2 by ganaxolone.
    Paul AM; Branton WG; Walsh JG; Polyak MJ; Lu JQ; Baker GB; Power C
    Neuroscience; 2014 Jul; 273():24-38. PubMed ID: 24814730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Periplocoside E inhibits experimental allergic encephalomyelitis by suppressing interleukin 12-dependent CCR5 expression and interferon-gamma-dependent CXCR3 expression in T lymphocytes.
    Zhu YN; Zhong XG; Feng JQ; Yang YF; Fu YF; Ni J; Liu QF; Tang W; Zhao WM; Zuo JP
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1153-62. PubMed ID: 16751252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved clinical behavior of established relapsing-remitting experimental autoimmune encephalomyelitis following treatment with endogenous opioids: implications for the treatment of multiple sclerosis.
    Hammer LA; Zagon IS; McLaughlin PJ
    Brain Res Bull; 2015 Mar; 112():42-51. PubMed ID: 25647234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IFN-β inhibits T cells accumulation in the central nervous system by reducing the expression and activity of chemokines in experimental autoimmune encephalomyelitis.
    Cheng W; Zhao Q; Xi Y; Li C; Xu Y; Wang L; Niu X; Wang Z; Chen G
    Mol Immunol; 2015 Mar; 64(1):152-62. PubMed ID: 25433436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction between the protective effects of cannabidiol and palmitoylethanolamide in experimental model of multiple sclerosis in C57BL/6 mice.
    Rahimi A; Faizi M; Talebi F; Noorbakhsh F; Kahrizi F; Naderi N
    Neuroscience; 2015 Apr; 290():279-87. PubMed ID: 25637488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of CB2 receptor is required for the therapeutic effect of ABHD6 inhibition in experimental autoimmune encephalomyelitis.
    Wen J; Ribeiro R; Tanaka M; Zhang Y
    Neuropharmacology; 2015 Dec; 99():196-209. PubMed ID: 26189763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. OLT1177 (Dapansutrile), a Selective NLRP3 Inflammasome Inhibitor, Ameliorates Experimental Autoimmune Encephalomyelitis Pathogenesis.
    Sánchez-Fernández A; Skouras DB; Dinarello CA; López-Vales R
    Front Immunol; 2019; 10():2578. PubMed ID: 31736980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thymosin beta4 promotes oligodendrogenesis in the demyelinating central nervous system.
    Zhang J; Zhang ZG; Li Y; Lu M; Zhang Y; Elias SB; Chopp M
    Neurobiol Dis; 2016 Apr; 88():85-95. PubMed ID: 26805386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physical Exercise Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Peripheral Immune Response and Blood-Brain Barrier Disruption.
    Souza PS; Gonçalves ED; Pedroso GS; Farias HR; Junqueira SC; Marcon R; Tuon T; Cola M; Silveira PCL; Santos AR; Calixto JB; Souza CT; de Pinho RA; Dutra RC
    Mol Neurobiol; 2017 Aug; 54(6):4723-4737. PubMed ID: 27447807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bevacizumab diminishes experimental autoimmune encephalomyelitis by inhibiting spinal cord angiogenesis and reducing peripheral T-cell responses.
    MacMillan CJ; Furlong SJ; Doucette CD; Chen PL; Hoskin DW; Easton AS
    J Neuropathol Exp Neurol; 2012 Nov; 71(11):983-99. PubMed ID: 23037326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.